Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Shyam SundarJaya Chakravarty

Abstract

Miltefosine is the only oral drug available for treatment of Indian visceral leishmaniasis (VL), which was shown to have an efficacy of 94% in a phase III trial in the Indian subcontinent. Its unrestricted use has raised concern about its continued effectiveness. This study evaluates the efficacy and safety of miltefosine for the treatment of VL after a decade of use in India. An open-label, noncomparative study was performed in which 567 patients received oral miltefosine (50 mg for patients weighing <25 kg, 100 mg in divided doses for those weighing ≥25 kg, and 2.5 mg per kg for those aged <12 years, daily for 28 days) in a directly observed manner. Patients were followed up for 6 months to see the response to therapy. At the end of treatment the initial cure rate was 97.5% (intention to treat), and 6 months after the end of treatment the final cure rate was 90.3%. The overall death rate was 0.9% (5 of 567), and 2 deaths were related to drug toxicity. Gastrointestinal intolerance was frequent (64.5%). The drug was interrupted in 9 patients (1.5%) because of drug-associated adverse events. As compared to the phase III trial that led to registration of the drug a decade ago, there is a substantial increase in the failure rate o...Continue Reading

References

May 1, 1983·The American Journal of Tropical Medicine and Hygiene·J D Chulay, A D Bryceson
Jan 29, 1994·BMJ : British Medical Journal·S SundarV P Singh
Dec 16, 1998·Lancet·S SundarH W Murray
Dec 10, 1999·The New England Journal of Medicine·T K JhaJ Berman
Oct 26, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S SundarH W Murray
Aug 31, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J SotoJ Berman
Nov 29, 2002·The New England Journal of Medicine·Shyam SundarJonathan Berman
Dec 31, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sujit K BhattacharyaJonathan D Berman
May 6, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J SotoH Sindermann
Jun 29, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Koert RitmeijerRobert N Davidson
Jul 4, 2006·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·F Javier Pérez-VictoriaFrancisco Gamarro
Jan 5, 2007·Indian Journal of Pediatrics·Utpal Kant SinghB P Jayswal
Jul 13, 2007·The Journal of Infectious Diseases·Sujit Kumar BhattacharyaNirmal Kumar Ganguly
Sep 11, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Shyam SundarHenry W Murray
Feb 12, 2010·The New England Journal of Medicine·Shyam SundarHenry W Murray
Jul 8, 2011·The American Journal of Tropical Medicine and Hygiene·Mahmudur RahmanByron Arana

❮ Previous
Next ❯

Citations

Oct 31, 2013·Drugs·Begoña Monge-Maillo, Rogelio López-Vélez
Jan 24, 2013·Proceedings of the National Academy of Sciences of the United States of America·Budhaditya MukherjeeSyamal Roy
Feb 22, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Suman RijalJean-Claude Dujardin
Aug 15, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sakib BurzaMaría Angeles Lima
Nov 15, 2012·The American Journal of Tropical Medicine and Hygiene·Dharmendra SinghPradeep Das
Nov 15, 2013·Proceedings of the National Academy of Sciences of the United States of America·Malcolm J McConville, Stuart A Ralph
May 31, 2014·Journal of Tropical Medicine·Shyam SundarOm Prakash Singh
Jan 21, 2014·The Journal of Infectious Diseases·Thomas P C DorloAlwin D R Huitema
Sep 26, 2014·Nanomedicine·C D Shaw, K C Carter
Oct 8, 2014·Travel Medicine and Infectious Disease·Pasquale MansuetoAntonio Cascio
Sep 11, 2014·Transactions of the Royal Society of Tropical Medicine and Hygiene·Sushmita DasPradeep Das
Oct 23, 2013·Antimicrobial Agents and Chemotherapy·Ricardo ObonagaNancy Gore Saravia
May 8, 2014·Expert Review of Anti-infective Therapy·Manu VanaerschotJean-Claude Dujardin
Dec 22, 2012·Expert Opinion on Pharmacotherapy·Shyam Sundar, Jaya Chakravarty
May 3, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Weverson A FerreiraCynthia Demicheli
Oct 28, 2014·Expert Opinion on Pharmacotherapy·Shyam Sundar, Jaya Chakravarty
Sep 26, 2015·Journal of Enzyme Inhibition and Medicinal Chemistry·Sambamurthy ChandrasekaranRadheshyam Maurya
Nov 21, 2014·Expert Opinion on Investigational Drugs·Shyam Sundar, Jaya Chakravarty
Nov 22, 2012·Expert Opinion on Emerging Drugs·Manica BalasegaramFrançois Chappuis
Feb 13, 2016·The Lancet Infectious Diseases·Sujit K Bhattacharya, Aditya Prasad Dash
Feb 19, 2013·Parasitology International·Sambamurthy ChandrasekaranRadheshyam Maurya
Mar 10, 2016·Infectious Diseases of Poverty·Om Prakash SinghShyam Sundar
Sep 14, 2015·European Journal of Medicinal Chemistry·Maria V PapadopoulouMarcel Kaiser
Dec 4, 2012·Tropical Medicine & International Health : TM & IH·Surendra UranwMarleen Boelaert
Dec 3, 2015·Tropical Parasitology·Shyam Sundar
Apr 20, 2016·European Journal of Medicinal Chemistry·Maria V PapadopoulouMarcel Kaiser
Jun 29, 2014·Chemico-biological Interactions·Ehab Kotb ElmahallawyAhmad Agil
Jul 3, 2013·FEMS Microbiology Reviews·Manu VanaerschotJean-Claude Dujardin
Sep 28, 2014·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Rao MukkavilliDenis Martin
Jan 21, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Begoña Monge-Maillo, Rogelio López-Vélez
Jan 8, 2015·Pharmaceutical Patent Analyst·Murugappan RamaSeetharaman Balaji
Feb 17, 2015·TheScientificWorldJournal·Shyam SundarMadhukar Rai
Sep 15, 2010·PLoS Neglected Tropical Diseases·Filip MeheusMarleen Boelaert

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Suman RijalJean-Claude Dujardin
The New England Journal of Medicine
Shyam SundarJ Berman
Expert Opinion on Drug Metabolism & Toxicology
Jonathan Josh Berman
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Shyam SundarH W Murray
© 2021 Meta ULC. All rights reserved